Radioimmunotherapy using 131I-rituximab in patients with advanced stage B-cell non-Hodgkin’s lymphoma: initial experience

被引：0
|
作者：
Maren Bienert
Ingrid Reisinger
Stefanie Srock
Beatrice I Humplik
Christel Reim
Thomas Kroessin
Norbert Avril
Antonio Pezzutto
Dieter L Munz
机构：
[1] Charité—Universitätsmedizin Berlin,Clinic for Nuclear Medicine
[2] Charité—Universitätsmedizin Berlin,Department of Haematology and Oncology
来源：
European Journal of Nuclear Medicine and Molecular Imaging | 2005年 / 32卷
关键词：
Non-Hodgkin’s lymphoma; Radioimmunotherapy; I-rituximab;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：1225 / 1233
页数：8
相关论文
共 50 条
  • [11] Radioimmunotherapy of B-cell non-Hodgkin's lymphoma
    Postema, EJ
    Boerman, OC
    Oyen, WJG
    Raemaekers, JMM
    Corstens, FHM
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE, 2001, 28 (11) : 1725 - 1735
  • [12] Radioimmunotherapy of B-cell non-Hodgkin's lymphoma
    Bodet-Milin, Caroline
    Ferrer, Ludovic
    Pallardy, Amandine
    Eugene, Thomas
    Rauscher, Aurore
    Faivre-Chauvet, Alain
    Barbet, Jacques
    Kraeber-Bodere, Francoise
    FRONTIERS IN ONCOLOGY, 2013, 3
  • [13] Different Time Courses of Radioimmunotherapy Using 131I-rituximab in Patients with Diffuse Large B-cell Lymphoma and Indolent Lymphoma
    Byeon, ByeongHyeon
    Kang, Hye Jin
    Choi, Chang Woon
    Lim, Sang Moo
    JOURNAL OF NUCLEAR MEDICINE, 2015, 56 (03)
  • [14] Clinical scale preparation and evaluation of 131I-Rituximab for Non-Hodgkin's Lymphoma
    Kameswaran, Mythili
    Vimalnath, K. Viswanathan
    Rajeswari, Ardhi
    Joshi, Prahlad Vasudeo
    Sarma, H. D.
    Samuel, Grace
    RADIOCHIMICA ACTA, 2014, 102 (06) : 553 - 560
  • [15] Personalized Dosimetry of 131I-Rituximab Radioimmunotherapy of Non-Hodgkin Lymphoma Defined by Pharmacokinetics in Bone Marrow and Blood
    Boucek, Jan A.
    Turner, J. Harvey
    CANCER BIOTHERAPY AND RADIOPHARMACEUTICALS, 2014, 29 (01) : 18 - 25
  • [16] Radioimmunotherapy for B-cell non-Hodgkin lymphoma
    Witzig, Thomas E.
    BEST PRACTICE & RESEARCH CLINICAL HAEMATOLOGY, 2006, 19 (04) : 655 - 668
  • [17] REPEATED RADIOIMMUNOTHERAPY (RIT) WITH I-131 RITUXIMAB IN PATIENTS WITH RELAPSED OR REFRACTORY B-CELL NON-HODGKIN'S LYMPHOMA (NHL); PRELIMINARY RESULTS
    Kang, H. J.
    Lim, S. M.
    Cheon, G. J.
    Choi, C. W.
    Lee, S. S.
    Na, I. I.
    Ryoo, B. Y.
    Kim, W. S.
    Nam, S. H.
    Park, Y. H.
    Suh, C.
    Eom, H. S.
    Yang, S. H.
    HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2008, 93 : 100 - 100
  • [18] Tandem myeloablative 131I-rituximab radioimmunotherapy and high-dose chemotherapy in refractory/relapsed non-Hodgkin lymphoma patients
    Deshayes, Emmanuel
    Kraeber-Bodere, Francoise
    Vuillez, Jean-Philippe
    Bardies, Manuel
    Teulon, Isabelle
    Pouget, Jean-Pierre
    IMMUNOTHERAPY, 2013, 5 (12) : 1283 - 1286
  • [19] REPEATED RADIOIMMUNOTHERAPY (RIT) WITH I-131 RITUXIMAB IN PATIENTS WITH RELAPSED OR REFRACTORY B-CELL NON-HODGKIN'S LYMPHOMA (NHL); PRELIMINARY RESULTS
    Kang, H. J.
    Lim, S. M.
    Cheon, G. J.
    Choi, C. W.
    Lee, S. S.
    Kim, W. S.
    Park, Y. H.
    Ryoo, B.
    Na, I. I.
    Yang, S. H.
    ANNALS OF ONCOLOGY, 2008, 19 : 232 - 232
  • [20] RADIOIMMUNOTHERAPY IN THE PATIENT WITH B-CELL NON-HODGKIN'S LYMPHOMA
    Fernandez Natalia, Garcia
    Cuellar Angeles, Flores
    Santiago Maria del Rosario, Mora
    Perez Cristina, Gonzalez
    ATENCION FARMACEUTICA, 2012, 14 (01): : 34 - +
12345